Argent Trust Co’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,969
Closed -$26K 450
2018
Q2
$26K Hold
5,969
﹤0.01% 430
2018
Q1
$34K Hold
5,969
0.01% 291
2017
Q4
$48K Hold
5,969
0.02% 254
2017
Q3
$59K Hold
5,969
0.02% 263
2017
Q2
$125K Buy
5,969
+2,055
+53% +$43.1K 0.05% 251
2017
Q1
$98K Hold
3,914
0.04% 248
2016
Q4
$111K Buy
3,914
+2,402
+159% +$67.1K 0.05% 247
2016
Q3
$32K Hold
1,512
0.01% 256
2016
Q2
$23K Hold
1,512
0.01% 245
2016
Q1
$31K Buy
+1,512
New +$33.6K 0.02% 240

Other funds holding IPCI

Argent Trust Co's IPCI Position: Q3 2018 in Review

Argent Trust Co sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 5,969 shares — an estimated $26K sold.

Argent Trust Co first reported a position in IPCI in Q1 2016 and held it in 10 quarters. The position peaked at $125K in Q2 2017. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

  • Argent Trust Co reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
  • Argent Trust Co sold 5,969 Intellipharmaceuticals International Inc. shares in Q3 2018, an estimated $26K.
  • Argent Trust Co first reported a position in Intellipharmaceuticals International Inc. in Q1 2016 and held it in 10 quarters.
  • Argent Trust Co's Intellipharmaceuticals International Inc. position peaked at $125K in Q2 2017.
  • 10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on Argent Trust Co's 13F filing for Q3 2018, filed 14 Nov 2018.